These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11179325)

  • 1. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.
    Grangette C; Müller-Alouf H; Goudercourt D; Geoffroy MC; Turneer M; Mercenier A
    Infect Immun; 2001 Mar; 69(3):1547-53. PubMed ID: 11179325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
    Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
    Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence.
    Grangette C; Müller-Alouf H; Geoffroy M; Goudercourt D; Turneer M; Mercenier A
    Vaccine; 2002 Sep; 20(27-28):3304-9. PubMed ID: 12213400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations.
    Reveneau N; Geoffroy MC; Locht C; Chagnaud P; Mercenier A
    Vaccine; 2002 Mar; 20(13-14):1769-77. PubMed ID: 11906764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.
    Robinson K; Chamberlain LM; Schofield KM; Wells JM; Le Page RW
    Nat Biotechnol; 1997 Jul; 15(7):653-7. PubMed ID: 9219268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli.
    Shaw DM; Gaerthé B; Leer RJ; Van Der Stap JG; Smittenaar C; Heijne Den Bak-Glashouwer M; Thole JE; Tielen FJ; Pouwels PH; Havenith CE
    Immunology; 2000 Aug; 100(4):510-8. PubMed ID: 10929079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
    Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
    Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies.
    Yasuda Y; Isaka M; Taniguchi T; Zhao Y; Matano K; Matsui H; Morokuma K; Maeyama J; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Jun; 21(21-22):2954-63. PubMed ID: 12798639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C.
    Norton PM; Wells JM; Brown HW; Macpherson AM; Le Page RW
    Vaccine; 1997; 15(6-7):616-9. PubMed ID: 9178460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets.
    Amuguni H; Lee S; Kerstein K; Brown D; Belitsky B; Herrmann J; Keusch G; Sonenshein A; Tzipori S
    Microbes Infect; 2012 May; 14(5):447-56. PubMed ID: 22198093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
    Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.
    Roberts M; Li J; Bacon A; Chatfield S
    Infect Immun; 1998 Jul; 66(7):3080-7. PubMed ID: 9632569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.
    Oliveira ML; Arêas AP; Campos IB; Monedero V; Perez-Martínez G; Miyaji EN; Leite LC; Aires KA; Lee Ho P
    Microbes Infect; 2006 Apr; 8(4):1016-24. PubMed ID: 16549380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria.
    Grangette C; Müller-Alouf H; Hols P; Goudercourt D; Delcour J; Turneer M; Mercenier A
    Infect Immun; 2004 May; 72(5):2731-7. PubMed ID: 15102782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.
    Robinson K; Chamberlain LM; Lopez MC; Rush CM; Marcotte H; Le Page RW; Wells JM
    Infect Immun; 2004 May; 72(5):2753-61. PubMed ID: 15102785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses.
    Marinaro M; Fasano A; De Magistris MT
    Infect Immun; 2003 Apr; 71(4):1897-902. PubMed ID: 12654806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.
    Galen JE; Gomez-Duarte OG; Losonsky GA; Halpern JL; Lauderbaugh CS; Kaintuck S; Reymann MK; Levine MM
    Vaccine; 1997; 15(6-7):700-8. PubMed ID: 9178472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue.
    Hagiwara Y; McGhee JR; Fujihashi K; Kobayashi R; Yoshino N; Kataoka K; Etani Y; Kweon MN; Tamura S; Kurata T; Takeda Y; Kiyono H; Fujihashi K
    J Immunol; 2003 Feb; 170(4):1754-62. PubMed ID: 12574339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of mouse antibody and lymphocyte responses during intranasal vaccination with a lipooligosaccharide-based conjugate vaccine.
    Hirano T; Jiao X; Chen Z; Van Waes C; Gu XX
    Immunol Lett; 2006 Nov; 107(2):131-9. PubMed ID: 17030407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines.
    Klein K; Mann JF; Rogers P; Shattock RJ
    J Control Release; 2014 Jun; 183():43-50. PubMed ID: 24657807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.